New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For CI;WCG;HNT;MOH;UNH;CVH;WLP;AGP;CNC;HS;HUM;AET;MDT;BSX;STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
October 30, 2014
16:30 EDTMOHMolina Healthcare says FY14 EPS may fall short of low end of prior guidance
Subscribe for More Information
16:30 EDTMOHMolina Healthcare reports Q3 adjusted EPS 83c, may not compare to consensus 42c
Subscribe for More Information
12:35 EDTMDTMedtronic CEO sees Covidien merger closing in early 2015
Subscribe for More Information
07:34 EDTMDT, STJEnteroMedics names Brad Hancock Chief Commercial Officer
Subscribe for More Information
06:25 EDTCICigna reports Q3 global medical customers of 14,346
06:02 EDTCICigna sees FY14 adjusted EPS $7.25-$7.45, consensus $7.35
Sees FY14 projected lgobal medical customer growth of 1%-2%.
06:01 EDTCICigna reports Q3 adjusted EPS $1.95, consensus $1.83
Subscribe for More Information
October 29, 2014
15:41 EDTCINotable companies reporting before tomorrow's open
Subscribe for More Information
08:20 EDTCNCCentene price target raised to $112 from $105 at Susquehanna
Subscribe for More Information
06:04 EDTWLPWellPoint sees medical membership in FY14 to be 37.2M-37.3M
Subscribe for More Information
06:03 EDTWLPWellPoint reports medical enrollment up 0.7% or 259K to 37.5M as of September 30
Subscribe for More Information
06:02 EDTWLPWellPoint sees FY14 EPS excl. items $8.75-$8.85, consensus $8.72
Sees FY14 revenue $73.25B-$73.5B, consensus $73.5B
06:01 EDTWLPWellPoint reports Q3 adjusted EPS $2.36, consensus $2.27
Subscribe for More Information
October 28, 2014
15:44 EDTWLPNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Southern Company (SO), consensus $1.07; Phillips 66 (PSX), consensus $1.75; Automatic Data Processing (ADP), consensus 60c; Praxair (PX), consensus $1.63; WellPoint (WLP), consensus $2.27; Exelon (EXC), consensus 73c; Eaton (ETN), consensus $1.23; Hess (HES), consensus $1.08; TE Connectivity (TEL), consensus $1.00; McGraw Hill Financial (MHFI), consensus 94c; Waste Management (WM), consensus 68c; Hershey (HSY), consensus $1.08; Ralph Lauren (RL), consensus $2.06; Wisconsin Energy (WEC), consensus 53c; Garmin (GRMN), consensus 71c; Sealed Air (SEE), consensus 46c; DENTSPLY (XRAY), consensus 60c; Goodyear Tire (GT), consensus 70c; Revlon (REV), one estimate 45c; Booz Allen (BAH), consensus 41c; Carlyle Group (CG), consensus 54c.
10:29 EDTCNCCentene management to meet with Oppenheimer
Subscribe for More Information
09:09 EDTMDTMedtronic initiates PERIGON pivotal trial
Subscribe for More Information
08:49 EDTWLPWellPoint volatility elevated into Q3 and outlook
WellPoint October weekly call option implied volatility is at 63, November is at 30, December is at 26, January is at 25; compared to its 26-week average of 24 according to Track Data, suggesting large near term price movement into the expected release of Q3 results on October 29.
07:38 EDTUNHOptum to acquire Alere Health in $600M cash transaction
Optum, part of UnitedHealth, and Alere announced that Optum has entered into a definitive agreement to acquire Alere Health and its subsidiaries, which provide condition management, case management, wellbeing, wellness and women’s and children’s health services to more than 200 regional and local health plans, 89 Fortune 500 employers and 29 states. Alere Health’s services are offered to more than 22 million people across the U.S. The $600M cash transaction is subject to customary regulatory approval and other closing conditions. Such conditions for Alere include consent of the required lenders under Alere’s senior secured credit facility. The transaction does not require the approval of Alere’s shareholders. Covington Associates is serving as financial advisor and Foley Hoag LLP is serving as legal advisor to Alere.
07:19 EDTMDTMB Venture Partners to hold a conference
Subscribe for More Information
06:19 EDTCNCCentene backs FY14 EPS view of $4.35-$4.50, consensus $3.83
Sees FY14 Premium and Service Revenues $15.3B-$15.8B.
06:16 EDTCNCCentene reports Q3 EPS $1.34, consensus 96c
Subscribe for More Information
06:05 EDTAETAetna reports Q3 Health Care business revenue $14B
The 14% increase is due primarily to membership growth in both of Aetna's Government and Commercial businesses, as well as the effects of pricing actions designed to recover the fees and taxes mandated by health care reform. Reports Q3 Group Insurance revenue $621.4M; Reports Q3 Large Case Pensions revenue $86.3M
06:04 EDTAETAetna reports Q3 medical membership totaled 23.6M at September 30, 2014
Sequentially, third-quarter 2014 medical membership increased by 470,000 due to growth in Aetna's Commercial ASC and Government products. Aetna's third-quarter 2014 Commercial MBR increased over the prior year's MBR primarily as a result of medical cost performance in the smaller middle-market business, costs associated with new hepatitis C treatments, and performance in the individual business, which reflects the impact of programs mandated by health care reform in 2014. This result was partially offset by higher premiums driven in part by pricing actions designed to recover the fees and taxes mandated by health care reform. In the third quarter of 2014, we experienced favorable development of prior-period health care cost estimates in each of our core products, primarily attributable to second quarter 2014 performance.
06:03 EDTAETAetna projects Coventry integratoin earnings accretion of 60c per share
Subscribe for More Information
06:03 EDTAETAetna raises FY14 operating EPS to $6.60-$6.70 from $6.45-$6.60, consensus $6.59
06:02 EDTAETAetna reports Q3 operating EPS $1.79, consensus $1.58
Subscribe for More Information
October 27, 2014
15:36 EDTAETNotable companies reporting before tomorrow's open
Subscribe for More Information
08:43 EDTHNTHealth Net sell-off a buying opportunity, says Susquehanna
Susquehanna said the recent sell-off in Health Net is a buying opportunity as the firm believes 2015 estimates remain very achievable even if California enrollments track 50% below consensus expectations. Susquehanna reiterates its Positive rating and $60 price target on Health Net shares.
08:04 EDTSTJSt. Jude Medical receives FDA approval of Tacticath Quartz catheter
Subscribe for More Information
07:28 EDTUNH, HUMMedical Group Management Association to hold a conference
Subscribe for More Information
06:14 EDTCNCCentene subsidiary recommended for contract award by Louisiana DHH
Centene announced that its wholly-owned Louisiana subsidiary, Louisiana Healthcare Connections, has been recommended for a contract award by the Louisiana Department of Health and Hospitals, or DHH, to serve its Bayou Health, or Medicaid, beneficiaries. A contract is contingent upon successful negotiations with DHH and approval by the Division of Administration and by the Centers for Medicare and Medicaid Services, or CMS, Regional Office. The new Bayou Health contract is expected to commence in early 1Q15. Under the new contract, Louisiana Healthcare Connections expects to serve 320,000-350,000 Medicaid beneficiaries on an at-risk basis via a network of 10,500 primary care providers and specialists. This expansion will more than double annual revenues for Louisiana Healthcare Connections.
October 26, 2014
12:49 EDTCNCCentene announces new claims processing facility
Subscribe for More Information
October 24, 2014
10:03 EDTHNTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:00 EDTHNTHealth Net downgraded to Sell from Buy at Citigroup
Citigroup downgraded Health Net two notches to Sell from Buy citing the stock's 60% year-to-date rally and its belief that 2015 consensus estimates are too high. Citi thinks the company's dual enrollment in California is tracking well short of projections. It raised its price target for shares to $42 from $35.
October 23, 2014
13:40 EDTAETWal-Mart's Sam's Club offering services to small businesses
Subscribe for More Information
10:01 EDTBSXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:33 EDTBSXBoston Scientific upgraded to Neutral from Sell at Goldman
Subscribe for More Information
October 22, 2014
14:17 EDTBSXBoston Scientific upgraded to Buy from Hold at Benchmark Co.
Price target $15.
13:58 EDTHUMHumana hires Goldman to explore sale of urgent care unit, Reuters reports
Humana has hired investment bank Goldman Sachs to advise on a potential sale of its urgent care subsidiary, Concentra, according to Reuters, citing three people familiar with the matter. A deal could value the subsidiary, which Humana acquired less than four years ago, at around $1B, the report noted. Reference Link
09:21 EDTBSXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Dow Chemical (DOW), up 3.7%... iRobot (IRBT), up 12%... Six Flags (SIX), up 13%... GlaxoSmithKline (GSK), up 2%... Broadcom (BRCM), up 7%... Boston Scientific (BSX), up 4.3%... Abbott (ABT), up 1.8%... Yahoo! (YHOO), up 6%. ALSO HIGHER: Blue Earth (BBLU), up 26.4% after CEO says statements in Seeking Alpha blog are "false and misleading."... GW Pharmaceuticals (GWPH), up 5.4% after Epidiolex receives orphan designation from EMA. DOWN AFTER EARNINGS: 3D Systems (DDD), down 15%... Biogen (BIIB), down 7%... Lumber Liquidators (LL), down 13.4%... Norfolk Southern (NSC), down 3%... Angie's List (ANGI), down 8.8%. ALSO LOWER: Nanosphere (NSPH), down 33% after filing secondary, reporting preliminary Q3 revenue... Himax Technologies (HIMX), down 16% after announcing that Google (GOOG) will not exercise an additional investment option in the company... Cree (CREE), down 10.5%, downgraded at DA Davidson and Canaccord following the company's Q1 earnings results... Ocwen Financial (OCN), down 7% after downgraded to Hold at Evercore, downgraded to Neutral at BofA Merrill Lynch... VMware (VMW), down 7.8%, downgraded at Nomura and Raymond James following the company's Q3 results.
08:43 EDTBSXBoston Scientific hasn't changed strategy in selling Synergy in Europe
Subscribe for More Information
08:25 EDTBSXBoston Scientific sees foreign exchange to be $55M headwind in FY14
Subscribe for More Information
08:16 EDTBSXBoston Scientific 'well ahead' of delivering EPS, revenue expectations
Subscribe for More Information
07:21 EDTMDT, STJU.S. DHS investigates medical gear for potential cyber defects, Reuters says
Subscribe for More Information
07:07 EDTBSXBoston Scientific raises FY14 adjusted EPS to 81c-83c from 79c-83c
Subscribe for More Information
07:06 EDTBSXBoston Scientific sees Q4 adjusted EPS 20c-22c, consensus 21c
Subscribe for More Information
07:05 EDTBSXBoston Scientific reports Q3 adjusted EPS 20c, consensus 20c
Subscribe for More Information
October 21, 2014
15:35 EDTBSXNotable companies reporting before tomorrow's open
Subscribe for More Information
09:52 EDTMDTCovidien rises after Medtronic maintains merger date language
Shares of Covidien (COV) are rising in early trading after Medtronic (MDT), in its latest regulatory filing answering questions for shareholders regarding its proposed takeover of the Irish drugmaker, left its language regarding the expected closing date unchanged. WHAT'S NEW: In its most recent filing, Medtronic again stated, "As of the date of this joint proxy statement/prospectus, the transaction is expected to be completed late in the fourth calendar quarter of 2014 or early 2015. However, no assurance can be provided as to when or if the transaction will be completed. The required vote of Medtronic and Covidien shareholders to adopt the required shareholder proposals at their respective special meetings, as well as the necessary regulatory consents and approvals, must first be obtained and other conditions specified in the conditions appendix must be satisfied or, to the extent applicable, waived." ANALYST REACTION: Research firm BTIG says Medtronic's amended regulatory filing on the Covidien transaction increases the firm's confidence of the deal closing by early 2015. The firm adds it would be "stunned" to see Medtronic walk away from the merger after the company again showed commitment to the acquisition. WHAT'S NOTABLE: AbbVie (ABBV) last night confirmed that the company and Shire (SHPG), another Irish domiciled drugmaker, agreed to terminate their proposed merger. AbbVie said its decision was based upon its assessment of the September 22 notice issued by the U.S. Department of Treasury, which re-interpreted longstanding tax principles in a "uniquely selective manner designed specifically to destroy the financial benefits of these types of transactions." AbbVie continued that the Treasury notice "introduced an unacceptable level of risk and uncertainty given the magnitude of the proposed changes" and the stated intention of the department to continue to revise tax principles to further impact such "tax inversion" transactions. AbbVie noted that it has agreed to pay Shire a break fee of approximately $1.64B due to the deal falling through. PRICE ACTION: In early trading, shares of Covidien trading in New York rose 4% to $88.86, Medtronic advanced 1% to $64.57, Shires gained 0.7% to $185.82 and AbbVie added 1.4% to $55.16.
09:43 EDTMDTAmended filing increases confidence in Covidien deal at BTIG
BTIG says Medtronic's (MDT) amended regulatory filing on the Covidien (COV) transaction increases its confidence of the deal closing by early 2015. The firm adds it would be "stunned" to see Medtronic walk away from the merger after the company again showed commitment to the acquisition. Shares of Covidien are up 3% to $88.11 in early trading.
09:11 EDTMDTMedtronic keeps language unchanged on merger closing date
Medtronic in its latest regulatory filing answering questions for shareholders regarding its proposed takeover of Covidien (COV) left the language unchanged around the expected closing date. The company again stated, "As of the date of this joint proxy statement/prospectus, the transaction is expected to be completed late in the fourth calendar quarter of 2014 or early 2015. However, no assurance can be provided as to when or if the transaction will be completed. The required vote of Medtronic and Covidien shareholders to adopt the required shareholder proposals at their respective special meetings, as well as the necessary regulatory consents and approvals, must first be obtained and other conditions specified in the conditions appendix must be satisfied or, to the extent applicable, waived."
09:03 EDTBSXBoston Scientific receives FDA and CE Mark approvals for CoverEdge leads
Subscribe for More Information
October 20, 2014
13:01 EDTWLPWellPoint renews agremeent with Healthways to continue SilverSneakers program
SilverSneakers Fitness program will continue to be available to most members of WellPoint’s (WLP) affiliated Medicare Advantage plans as a result of its renewed agreement with Healthways (HWAY), which administers the popular program. SilverSneakers offers fitness programs geared toward older adults, including strength training and aerobic and flexibility exercises. The program offers WellPoint affiliated Medicare Advantage members full memberships at participating fitness facilities nationwide at no extra cost.
08:16 EDTBSXBoston Scientific initiates PLATINUM Diversity trial
Subscribe for More Information
07:20 EDTBSX, MDTInternational Continence Society to hold annual meeting
ICS Annual Meeting 2014 is being held in Rio de Janeiro, Brazil on October 20-24.
07:12 EDTMDT, STJCongress of Neurological Surgeons to hold annual meeting
Subscribe for More Information
07:11 EDTBSXAmerican Society for Reproductive Medicine to hold annual meeting
2014 Annual Meeting of ASRM is being held in Honolulu on October 18-22.
October 17, 2014
10:00 EDTUNHOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AK Steel (AKS) upgraded to Buy from Neutral at Nomura... AMD (AMD) upgraded to Sector Perform from Underperform at Pacific Crest... Atlantic Power (AT) upgraded to Market Perform from Underperform at BMO Capital... Basic Energy (BAS) upgraded to Outperform from Market Perform at Cowen... BorgWarner (BWA) upgraded to Buy from Hold at Deutsche Bank... CA Technologies (CA) upgraded to Overweight from Equal Weight at Barclays... Calumet Specialty Products (CLMT) upgraded to Outperform at Wells Fargo... DHT Holdings (DHT) upgraded to Buy from Hold at Evercore... Exelon (EXC) upgraded to Neutral from Sell at Citigroup... Fifth Third Bancorp (FITB) upgraded to Buy from Neutral at Citigroup... Goldman Sachs (GS) upgraded to Outperform from Market Perform at Keefe Bruyette... Helmerich & Payne (HP) upgraded to Buy from Neutral at UBS... Hilton (HLT) upgraded to Buy from Neutral at SunTrust... Hyatt Hotels (H) upgraded to Outperform from Neutral at Macquarie... IPG Photonics (IPGP) upgraded at Stifel... ITC Holdings (ITC) upgraded to Neutral from Underperform at Credit Suisse... Manpower (MAN) upgraded to Outperform from Market Perform at Avondale... Nabors Industries (NBR) upgraded to Outperform from Market Perform at Cowen... Newpark Resources (NR) upgraded at Cowen... Old Dominion (ODFL) upgraded to Buy from Neutral at Longbow... PDC Energy (PDCE) upgraded at SunTrust... Patterson-UTI (PTEN) upgraded to Buy from Neutral at UBS... PrivateBancorp (PVTB) upgraded to Outperform from Neutral at Macquarie... QLogic (QLGC) upgraded to Buy from Hold at Summit Research... RPC, Inc. (RES) upgraded at Cowen... Sonoco (SON) upgraded to Neutral from Underperform at DA Davidson... Southwestern Energy (SWN) upgraded to Outperform from Market Perform at Raymond James... SunEdison (SUNE) upgraded to Outperform at Cowen... TSMC (TSM) upgraded to Buy from Neutral at Mizuho... Tesco (TESO) upgraded to Outperform from Market Perform at Cowen... UnitedHealth (UNH) upgraded to Outperform from Market Perform at Leerink... Xilinx (XLNX) upgraded to Outperform from Market Perform at Wells Fargo.
07:27 EDTUNHUnitedHealth upgraded to Outperform from Market Perform at Leerink
Subscribe for More Information
06:09 EDTUNHUnitedHealth upgraded to Outperform from Market Perform at Leerink
Subscribe for More Information
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use